Validated QPS Assays
The vast majority of today’s modern bioanalytical methods for pharmacokinetics, pharmacodynamics, and immunogenicity assessment are based on mass spectrometry and/or immuno-bioanalytical approaches. However, for a small but important number of compounds, LC MS/MS or LBA are less than satisfactory. A good alternative is Inductively Coupled Plasma Mass Spectrometry (ICP-MS). In ICP MS, the samples are ionized by an inductively coupled plasma (ionization source) and the ions of interest are separated, detected, and quantitated by a mass spectrometer.
The QPS Assay Finder contains a broad range of validated assays for all of your bioanalytical needs.
Search For An Assay Here
Copper (total)
Matrix: | Human Urine |
Assay Range: | 5.00-200 ng/mL |
Sample Volume: | 50 µL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 & -70 |
Platform: | ICP-MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Drug Assays |
Copper (total)
Matrix: | Human Serum |
Assay Range: | 50.0-5,000 ng/mL |
Sample Volume: | 10 µL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 & -70 |
Platform: | ICP-MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Drug Assays |
Corticosterone
Matrix: | Mouse Plasma |
Assay Range: | 1.0 - 145 ng/mL |
Sample Volume: | 0.03 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | ELISA |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Corticosterone
Matrix: | Rat Plasma |
Assay Range: | 1.1 - 164 ng/mL |
Sample Volume: | 0.03 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | ELISA |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Cortisol
Matrix: | Dog Plasma |
Assay Range: | 0.500 - 60.0 µg/dL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | ELISA |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Cortisol
Matrix: | Human Plasma |
Assay Range: | 0.500 - 60.0 µg/gL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | Citrate |
Storage Temperature (°C): | -20 |
Platform: | ELISA |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Cortisol (free fraction)
Matrix: | Human Serum |
Assay Range: | 5.0 - 500 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | LC-MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Cortisol (free freaction)
Prednisolone (free fraction)
Prednisolone (free fraction)
Matrix: | Human Serum |
Assay Range: | 5.00 - 500 ng/mL 1.00 - 500 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Antiinflammatory |
Classification: | Drug Assays |
Cortisol
6ß-hydroxycortisol
6ß-hydroxycortisol
Matrix: | Human Urine |
Assay Range: | 1.00 - 1,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Cortisol
6ß-hydroxycortisol
6ß-hydroxycortisol
Matrix: | Human Urine |
Assay Range: | 1 - 150 ng/mL 5 - 750 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Cortisol
6ß-hydroxycortisol
6ß-hydroxycortisol
Matrix: | Human Urine |
Assay Range: | 1 - 150 ng/mL 5 - 750 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | UPLC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Cortisol
Prednisolone
Prednisolone
Matrix: | Human Serum |
Assay Range: | 5.00 - 500 ng/mL 2.50 - 500 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Antiinflammatory |
Classification: | Drug Assays |
Creatinine
Matrix: | Human Urine |
Assay Range: | 0.1 - 2 mM |
Sample Volume: | 0.02 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | Colorimetric |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Creatinine
Matrix: | Human Urine |
Assay Range: | 0.400 - 40.0 µg/mL |
Sample Volume: | 0.01 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | HPLC-UV |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Cyclobenzaprine
Matrix: | Human Plasma |
Assay Range: | 0.2 - 60 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Muscle Relaxant |
Classification: | Drug Assays |
Cyclobenzaprine
Matrix: | Human Plasma |
Assay Range: | 0.1 - 100 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Muscle Relaxant |
Classification: | Drug Assays |
Cyclophosphamide
Fludarabine
Fludarabine
Matrix: | Human Plasma |
Assay Range: | 2.00 - 2,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
Cyclosporin A
Matrix: | Human Whole Blood |
Assay Range: | 5.00 - 5,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Antibiotic |
Classification: | Drug Assays |
Cyclosporin A
Matrix: | Human Whole Blood |
Assay Range: | 2 - 1,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antibiotic |
Classification: | Drug Assays |
CYP2B6 (*5A, *9 , *18) Genotyping
Matrix: | Human Whole Blood |
Assay Range: | N.Ap. |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -80 |
Platform: | TaqMan |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Genomic Biomarkers |
CYP2C19 (*2, *3, *4, *5, *6, *8) Genotyping
Matrix: | Human Whole Blood |
Assay Range: | N.Ap. |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -80 |
Platform: | TaqMan |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Genomic Biomarkers |
CYP2C8 (*1B, *1C, *2, *3, *4) Genotyping
Matrix: | Human Whole Blood |
Assay Range: | N.Ap. |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -80 |
Platform: | TaqMan; QuantStudio |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Genomic Biomarkers |
CYP2C9 (*2, *3, *4, *5) Genotyping
Matrix: | Human Whole Blood |
Assay Range: | N.Ap. |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -80 |
Platform: | Pyrosequencing |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Genomic Biomarkers |
CYP2C9 (*8, *11, *13) Genotyping
Matrix: | Human Whole Blood |
Assay Range: | N.Ap. |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -80 |
Platform: | TaqMan; 7900 |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Genomic Biomarkers |
CYP2D6 (*3, *3b, *5-2xN, *6, *7, *8, *10, *11, *14) Genotyping
Matrix: | Human Whole Blood |
Assay Range: | N.Ap. |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -80 |
Platform: | Pyrosequencing |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Genomic Biomarkers |
Links to Relevant Documents
Testimonials
Thanks for the good news, I’m happy to see that within less than a month you will have developed and validated the assay. Good Job!
QPS CLIENT